We found that low NUAK1 expression levels significantly correlates with better prognosis and relapse-free survival in some tumour subtypes: ER-negative (p = 0.00033), HER2-positive (p = 0.004) and luminal B (p = 0.003) subtypes (Fig. 4a). Here, NUAK1 is linked to neoplasm.